Skip to main content
. 2018 Nov 24;5(1):e000236. doi: 10.1136/bmjgast-2018-000236

Table 6.

Patient characteristics type of disease—health-related information

CD UC IBD_NS All
Age at diagnosis
 0–5 years 44 (11.1%) 23 (11.3%) 19 (30.6%) 86 (13.0%)
 6–9 years 139 (35.0%) 73 (35.8%) 19 (30.6%) 231 (34.8%)
 10–13 years 190 (47.9%) 92 (45.1%) 20 (32.3%) 302 (45.6%)
>14 years 24 (6.0%) 16 (7.8%) 4 (6.5%) 44 (6.6%)
Course during last year
 Stable remission 161 (40.4%) 85 (41.3%) 29 (46.0%) 275 (41.2%)
 One relapse 116 (29.1%) 49 (23.8%) 20 (31.7%) 185 (27.7%)
 More relapses/chronically active 122 (30.6%) 72 (35.0%) 14 (22.2%) 208 (31.1%)
Current health status
 Good 261 (65.1%) 137 (66.5%) 40 (63.5%) 438 (65.4%)
 Moderate 115 (28.7%) 46 (22.3%) 19 (30.2%) 180 (26.9%)
 Poor 25 (6.2%) 23 (11.2%) 4 (6.3%) 52 (7.8%)
Disease duration
 <1 years 57 (14.3%) 29 (14.1%) 11 (17.5%) 97 (14.5%)
 1 to <2 years 61 (15.3%) 29 (14,1%) 8 (12.7%) 98 (14.7%)
 2 to <5 years 167 (41.9%) 84 (41.0%) 17 (27.0%) 268 (40.2%)
 5 years+ 114 (8.5%) 63 (30.7%) 27 (42.9%) 204 (30.7%)
Resecting surgery
 Has had surgery 31 (7.7%) 12 (5.8%) 2 (3.2%) 45 (6.7%)
Therapy
 Ever had corticosteroids 284 (83.8%) 153 (86.9%) 36 (69.2%) 473 (83.4%)
 Ever had biological 131 (32.4%) 31 (14.9%) 10 (15.9%) 172 (25.5%)
 Ever had immunomodulators 334 (82.7%) 137 (65.9%) 27 (57.1%) 498 (74.1%)
Total 404 208 63 675